LRRK2 and Parkinson disease: Moreover, the combination of TMAO-induced aging organoids with genetic PD modeling, such as the LRRK2 mutation, would provide an opportunity to study the role of TMAO in the pathogenesis of PD, which could be an advanced human PD model.